Salmonella membrane pore protein OmpC and application thereof in detection
By constructing recombinant positive transformants and prokaryotic system expression, the preparation and detection application of salmon membrane porein OmpC is solved, effective methods for salmonella detection and vaccine preparation are realized, and efficient and low-cost OmpC protein is provided for ELISA detection. .
Patent Information
- Application Number
- CN202411238972.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-11-22
- Filing Date
- 2024-09-05
- Publication Date
- 2024-11-26
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The lack of effective preparation method for salmon membrane porin OmpC and its application in detection in the prior art limits the detection of salmon bacteria and vaccine preparation.
By constructing recombinant positive transformants, expressing and purifying the OmpC protein of Salmonella ATCC 9120, expressing and purifying the prokaryotic system and undergoing multiple purification and dialysis reproducibility treatments, the salmon membrane pore protein OmpC that can be used for ELISA detection was prepared, and the salmon membrane pore protein OmpC can be used for ELISA detection was put into use. It is used in the preparation of high-free serum and ELISA detection.
It realizes the efficient preparation and detection application of salmon membrane porin OmpC. The method is simple and low-cost, and is suitable for large-scale preparation and ELISA detection, with good application prospects.
Smart Images

Figure CN119020386A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biotechnology, and more specifically to a Salmonella membrane porin OmpC and an application thereof in detection. Background Art
[0002] Bacteria are able to regulate the entry and exit of many molecules by regulating the expression of porins and efflux pumps. Among them, porins, also known as outer membrane proteins (OMPs), are β-barrel proteins embedded in the OMP of Gram-negative bacteria, allowing passive diffusion of molecules. Porins also act as receptors for bacteriophages and bacteriocins, and together with peptidoglycan and LPS, play an important role in maintaining the integrity of bacterial cells. Therefore, changes in OMP expression levels lead to changes in outer membrane permeability.
[0003] There is still little research on bacterial Omp in my country. The bacterial OmpC gene is an important gene that encodes bacterial Omp antigens. The membrane pore protein OmpC can be used as an adjuvant and an immunostimulant. The membrane pore protein OmpC can activate the body's immune response through the classical pathway. Therefore, it is of great significance to prepare and purify the OmpC protein for the detection of Salmonella and the subsequent preparation of Salmonella vaccines. Summary of the invention
[0004] The technical problem to be solved by the present invention is to overcome the above problems existing in the prior art and provide a method for preparing Salmonella membrane porin OmpC.
[0005] The second object of the present invention is to provide the use of the above-mentioned Salmonella membrane porin OmpC in detection.
[0006] The purpose of the present invention is achieved through the following technical solutions:
[0007] A method for preparing Salmonella membrane porin OmpC comprises the following steps:
[0008] S1. Construction of recombinant positive transformants: using the whole genome of Salmonella pullorum ATCC 9120 as a template to amplify the target gene OmpC, recombining the target gene OmpC with a plasmid vector, and then transforming and screening to obtain recombinant positive transformants;
[0009] S2. Expression and purification of target protein: The recombinant positive transformant strain was cultured for IPTG-induced expression, and the induced bacterial precipitate was resuspended in a buffer containing 8M urea, and then purified after crushing and filtration; the IPTG induction conditions were: IPTG concentration 100mM, induction time 16h, induction temperature 16°C;
[0010] S3. Dialysis renaturation: The purified protein was dialyzed in dialysis bags containing 6M, 4M, 2M, 1M, and 0M dialysis solutions, respectively. The dialysis solution was changed every 4 hours. After the dialysis was completed, the Salmonella membrane porin OmpC was obtained.
[0011] Since the OmpC protein expressed by the prokaryotic system is an inclusion body protein, the purification conditions and dialysis refolding conditions were explored many times according to the characteristics of the inclusion body protein. During the purification, expression and dialysis process, the conditions were explored and the above conditions were obtained.
[0012] The present invention also provides the use of the Salmonella membrane porin OmpC obtained by the above method in preparing a reagent for detecting Salmonella. Preferably, the reagent is an ELISA detection reagent.
[0013] The present invention also provides application of the Salmonella membrane porin OmpC in preparing high-immune serum.
[0014] Specifically, the Salmonella membrane pore protein OmpC is used to immunize animals. The immunization operation is as follows: on the 0th day, 100ug of purified OmpC protein and an equal volume of complete Freund's adjuvant are injected; then on the 5th day, the 10th day, and the 15th day, 100ug of purified OmpC protein and an equal volume of incomplete Freund's adjuvant are inoculated in the same way.
[0015] A specific embodiment of the above application is: using the membrane porin OmpC as a coating antigen in the ELISA detection process, and the antigen can well detect the relative content of the OmpC protein in the high immune serum.
[0016] Compared with the prior art, the present invention has the following beneficial effects:
[0017] The present invention discloses a salmonella membrane pore protein OmpC and its application in detection. The OmpC protein is expressed by a prokaryotic expression system Escherichia coli BL21 (DE3). Since the OmpC protein expressed by the prokaryotic system is an inclusion body protein, purification conditions and dialysis renaturation conditions are explored multiple times according to the characteristics of the inclusion body protein; finally, the obtained OmpC protein is used as a coating antigen for an Elisa detection plate. The protein preparation method of the present invention is simple, low in cost, easy to prepare in large quantities, can be applied to the ELISA detection method, and has good application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Figure 1 This is a WB comparison of OmpC protein after the bacteria were treated with buffer A containing 8 M urea and without 8 M urea;
[0019] Figure 2is the SDS-polyacrylamide gel electrophoresis diagram of OmpC protein, lane 1 represents the OmpC protein before purification, and lanes 2 and 3 represent the OmpC protein after purification;
[0020] Figure 3 It is the standard curve for measuring the concentration of target protein;
[0021] Figure 4 To prepare a high-immune serum immunization program;
[0022] Figure 5 Elisa was used to measure the specific antibody level of OmpC protein in serum. DETAILED DESCRIPTION
[0023] The specific embodiments of the present invention are further described below. It should be noted that the description of these embodiments is used to help understand the present invention, but does not constitute a limitation of the present invention. In addition, the technical features involved in each embodiment of the present invention described below can be combined with each other as long as they do not conflict with each other.
[0024] The embodiments of the present invention are described in detail above, but the present invention is not limited to the described embodiments. For those skilled in the art, various changes, modifications, substitutions and variations of these embodiments are made without departing from the principles and spirit of the present invention, and still fall within the protection scope of the present invention.
[0025] Example 1 Preparation of Salmonella membrane porin OmpC
[0026] 1. Construction of recombinant protein
[0027] The following steps are involved:
[0028] (1) Obtaining the target gene: During the exploratory experiment, the whole genome of the clinical strain Salmonella pullorum SP 376 was extracted and the target gene OmpC was amplified using the whole genome as a template. Comparison revealed that OmpC is highly conserved in Salmonella and that this sequence has a very high homology among different strains of Salmonella. Therefore, Salmonella pullorum ATCC 9120 was used in subsequent experiments.
[0029] The whole genome of Salmonella pullorum ATCC 9120 (NZ_CP012347.1) was extracted, and the target gene OmpC was amplified using the whole genome as a template. The amplification primer sequences were: ompC-Infusion-F: tggacagcaaatgggtcgcggatccatgaaaaaagtagtggtgttatctgc, ompC-Infusion-R: gtcgacggagctcgaattcggatcctcagtggtggtggtggtggtgaaactcgtagactaagccga. After amplification, the target gene was recovered by gel and its DNA concentration was determined;
[0030] (2) Vector construction: The target gene fragment and the plasmid vector pET-28a were used to construct a recombinant vector by homologous recombination;
[0031] (3) Transformation: The constructed recombinant plasmid was introduced into competent BL21 (DE3) through transformation, and the transformed product was spread on LB agar plates containing 30 ug / mL kanamycin;
[0032] (4) Screening of positive recombinants: single colonies on the agar plate were selected for PCR verification and sequencing.
[0033] 2. Expression and purification of target protein
[0034] The following steps are involved:
[0035] (1) IPTG-induced expression: The constructed strain containing the target gene was inoculated into 4 ml of LB broth and cultured in a shaker at 37°C and 180 rpm for 4 h. Then, the strain was transferred to 200 ml of LB broth at a volume ratio of 1:100 and continued to be cultured until the logarithmic growth phase. Then, 100 mM IPTG was added to induce expression at 16°C and 180 rpm for 16 h.
[0036] (2) The induced bacterial solution was centrifuged and washed three times with PBS. Finally, the bacterial pellet was resuspended in buffer A solution containing 8 M urea, and then disrupted with a low-temperature ultrahigh pressure protein disruptor. After disruption, centrifugation was performed and the supernatant was collected and filtered with a 0.22 μm filter membrane;
[0037] Buffer A: 0.592 g NaH2PO4·2H2O + 2.3 g Na2HPO4 + 40 mM imidazole + 29.22 g NaCl, adjust pH to 7.4, add water to make up to 1000 mL.
[0038] (4) Purification of inclusion body protein: The filtered solution was purified using an AKTA protein purifier according to the method for purifying inclusion body protein to obtain the purified target protein. The specific purification steps were as follows: a nickel column was installed, and the instrument was first cleaned and balanced in the order of 30 mL 20% ethanol-30 mL pure water-30 mL 100% Buffer A, and then the sample was loaded. After the sample was loaded, the instrument was rinsed with 30 mL 100% Buffer A, and then the protein was gradient eluted according to the procedure of Buffer B from 0% to 100%. After the elution procedure was completed, the purifier was cleaned in the order of 30 mL 100% Buffer B-30 mL 100% Buffer A-30 mL pure water-30 mL 20% ethanol, and the purified protein was recovered.
[0039] (5) Dialysis refolding: Prepare 6M, 4M, 2M, 1M, and 0M dialysates, such as the formula of 6M dialysate: 10% glycerol + PBS + 0.5M arginine + 6M urea, and adjust the pH to 7.4; the same applies to dialysates of other concentrations. Precool the prepared dialysate at 4°C for later use. Place the purified protein in a 10KD dialysis bag and dialyze it in a magnetic stirrer at 4°C. Change the dialysate every 4 hours. Perform dialysis at a concentration of 6M-4M-2M-1M-0M.
[0040] 3. Determination of the concentration of target protein
[0041] The protein concentration was determined by Bradford method (Coomassie Brilliant Blue method) according to the kit instructions. According to the following standard curve ( Figure 3 ) calculated, the protein concentration of OmpC after renaturation was 682 μg / mL.
[0042] Example 2 Feasibility study of OmpC in ELISA detection
[0043] 1. Preparation of highly immune serum
[0044] Three SPF chickens, each aged 18 weeks (A) and 44 weeks (B), were housed in six separate cages and provided with free access to feed and water and were acclimated for 5 days.
[0045] Wing vein blood sampling: 2 ml of blank blood samples were collected from chickens on day 0 of the experiment, numbered A1-0 and B1-0, and then blood samples were collected on the 3rd, 13th and 23rd days.
[0046] Immunization: On day 0 of the experiment, chickens were immunized through the breast muscle with 100 ug of purified OmpC protein and an equal volume of complete Freund's adjuvant. Then, on days 5, 10, and 15, 100 ug of purified OmpC protein and an equal volume of incomplete Freund's adjuvant were inoculated in the same manner. The specific immunization procedure is as follows: Figure 4 shown.
[0047] 2. ELISA method to determine immune results
[0048] (1) Coating: Dilute the purified OmpC protein to 2.5 ug / ml using CBS (carbonate buffer) at pH 9.6, and add 100 ul of the dilution to each 96-well ELISA plate. Seal the plate and coat at 4°C for 16 h.
[0049] (2) Washing: Discard the protein solution in the wells and wash three times with PBST (0.05% Tween 20). After adding TBST each time, let it stand for 3 min before discarding it;
[0050] (3) Blocking: Prepare 5% BSA solution, 150 μl per well, and incubate at 37°C for 2 h;
[0051] (4) Add test samples: discard the blocking solution in the wells, pat dry, and then add the high immune serum prepared above. Pipette 100ul of antiserum (1 / 4000, 1 / 8000, 1 / 16000, 1 / 32000, 1 / 64000, 1 / 128000, 1 / 256000, 1 / 512000, 1024000, 1 / 2048000, 1 / 4096000) diluted in PBST (0.05% Tween20) and add it to the wells. Repeat 3 times for each group, and incubate at 37°C for 1 hour.
[0052] (5) Washing: Discard the antiserum in the wells and wash three times with PBST (0.05% Tween 20). After adding TBST each time, let it stand for 3 min before discarding it.
[0053] (6) Secondary antibody: HRP-labeled goat anti-chicken secondary antibody (1 / 2000) was diluted with PBST (0.05% Tween 20), 100 μL / well, incubated at 37°C for 1 h, and then washed three times with PBST (0.05% Tween 20). After adding TBST each time, let it stand for 3 min before discarding it;
[0054] (7) Color development: Add 100 μL / well of TMB color development solution and incubate at 37°C in the dark for 15 min.
[0055] (8) Termination: Add 100 μL / well 2M H2SO4 to terminate the reaction for 2 min;
[0056] (9) Data reading: Detect the OD value at OD450nm using a multifunctional microplate reader;
[0057] (10) Data processing: Use Graphpad to process the data and draw a graph. The results are as follows: Figure 5 As shown, the OD values measured by ELISA with blank serum (0d) were all very low, that is, the content of OmpC antibodies in chicken serum was very small, which was in line with expectations; within a certain range, with the increase in the number of immunizations, the OD value also increased, and the corresponding OmpC antibody content in the serum detected by ELISA also increased, indicating that it is feasible to use homemade OmpC protein as a coating protein for relative quantification in ELISA detection.
Claims
1. A method for preparing Salmonella membrane porin OmpC, characterized in that: The following steps are involved: S1. Construction of recombinant positive transformants: using the whole genome of Salmonella pullorum ATCC 9120 as a template to amplify the target gene OmpC, recombining the target gene OmpC with a plasmid vector, and then transforming and screening to obtain recombinant positive transformants; S2. Expression and purification of target protein: The recombinant positive transformant strain was cultured for IPTG-induced expression, and the induced bacterial precipitate was resuspended in a buffer containing 8M urea, and then purified after crushing and filtration; the IPTG induction conditions were: IPTG concentration 100mM, induction time 16h, induction temperature 16°C; S3. Dialysis renaturation: The purified protein was dialyzed in dialysis bags containing 6M, 4M, 2M, 1M, and 0M dialysis solutions, respectively. The dialysis solution was changed every 4 hours. After the dialysis was completed, the Salmonella membrane porin OmpC was obtained.
2. Use of the Salmonella membrane porin OmpC obtained by the preparation method according to claim 1 in preparing a reagent for detecting Salmonella.
3. The use according to claim 2, characterized in that: The reagent is an ELISA detection reagent.
4. Use of the Salmonella membrane porin OmpC according to claim 1 in the preparation of high immune serum.
5. The use according to claim 4, characterized in that: The Salmonella membrane pore protein OmpC is used to immunize animals. The immunization operation is as follows: on the 0th day, 100ug of purified OmpC protein and an equal volume of complete Freund's adjuvant are injected; then on the 5th day, the 10th day, and the 15th day, 100ug of purified OmpC protein and an equal volume of incomplete Freund's adjuvant are inoculated in the same way.
Citation Information
Patent Citations
Preparation method of salmonella membrane pore protein OmpC and application of salmonella membrane pore protein OmpC in detection
CN117683799A
